Assisted reproductive technology and perinatal outcomes explained

Across Australia, the number of babies conceived through assisted reproductive technology continues to climb year after year. Figures from the Australian and New Zealand Assisted Reproduction Database suggest that more than 4% of all live births each year now follow some form of fertility treatment, with clinics from Sydney to Perth reporting steady demand from single parents, same-sex couples, and heterosexual couples facing infertility. The techniques themselves have evolved well beyond the original in vitro fertilisation protocols of the late 1970s, and so too has the medical community's understanding of how conception in a laboratory dish shapes the weeks that follow.

For expectant parents and the clinicians who support them, perinatal outcomes remain the central concern. The perinatal window, stretching from late pregnancy through the first month of life, sets the trajectory for infant health in ways that researchers are still mapping. When conception occurs through techniques such as IVF, intracytoplasmic sperm injection, or frozen embryo transfer, questions naturally arise about rates of preterm birth, birth weight, placental function, and the likelihood of complications that may require neonatal intensive care.

These questions formed an important part of the scientific dialogue at the Federation of Asian and Oceania Perinatal Societies congress, where clinicians gathered to exchange evidence on how conception mode influences pregnancy, delivery, and the early neonatal period. Although the in-person meeting in Tokyo was halted by the COVID-19 pandemic, the published abstracts continue to inform practice across the region, including at tertiary centres in Brisbane, Melbourne, and Adelaide that manage high-risk pregnancies every week.

This overview walks through what is currently known about assisted conception and perinatal health, examines the most common complications that arise, and offers practical context for parents weighing their options or navigating an ART pregnancy.

Understanding the main methods of assisted conception

Assisted reproductive technology encompasses several distinct procedures, each with its own clinical pathway and risk profile. Conventional IVF involves stimulating the ovaries, retrieving eggs, fertilising them with sperm in a culture dish, and transferring one or more embryos back into the uterus. Intracytoplasmic sperm injection follows the same ovarian stimulation and embryo transfer stages but introduces a single sperm directly into each egg, a technique widely used in Australian clinics when male factor infertility is identified.

Frozen embryo transfer has become increasingly common in this country since vitrification methods improved. Many Australian fertility specialists now recommend elective single embryo transfer with a subsequent frozen cycle, partly because evidence from the Australian Institute of Health and Welfare suggests cumulative live birth rates are comparable to fresh transfers while reducing some maternal risks. Donor gametes, surrogacy arrangements, and the use of preimplantation genetic testing round out the broader landscape of treatment options available to families.

It is worth remembering that the chosen technique influences the hormonal environment at implantation, the quality of the endometrium, and in some cases the epigenetic programming of the early embryo. These biological differences, rather than the underlying infertility alone, appear to drive many of the variations in perinatal outcomes that researchers have observed.

Pregnancy complications linked to fertility treatment

Several complications occur more frequently in ART pregnancies than in naturally conceived pregnancies, even after accounting for maternal age and underlying health conditions. Hypertensive disorders of pregnancy, including pre-eclampsia, are consistently reported at higher rates in IVF and ICSI cohorts. Placentation differences, particularly when a frozen embryo is transferred into a uterus that has not recently undergone ovarian stimulation, are thought to contribute.

Gestational diabetes also appears more often, a finding relevant to Australian obstetricians who manage large multicultural patient populations with varying baseline risk. First trimester bleeding, miscarriage, and the need for caesarean delivery are additional concerns documented across multiple international registries.

Australian research published through the Murdoch Children's Research Institute has helped clarify some of these patterns, confirming that much of the elevated risk reflects parental characteristics rather than the technology itself. Even so, most antenatal guidelines now classify ART pregnancies as requiring closer surveillance, particularly when additional risk factors such as advanced maternal age or obesity are present. Specialist teams at the Royal Women's Hospital in Melbourne and the Royal Prince Alfred in Sydney routinely adjust their monitoring schedules for women who conceive through treatment.

Multiple pregnancies and neonatal concerns

The single biggest driver of adverse neonatal outcomes after ART has historically been multiple pregnancy. When two or more embryos are transferred, the chance of twins or triplets rises sharply, and with it the likelihood of preterm birth, low birth weight, and prolonged stays in neonatal intensive care. Australia has led the world in tackling this issue through aggressive elective single embryo transfer policies supported by Medicare funding that does not penalise patients for choosing a safer approach.

Since these policies took hold, twin rates following IVF have fallen dramatically in every state. The downstream effect on neonatal units has been substantial, with fewer very preterm infants admitted for respiratory support and other complications. Where multiples still occur, the workload on tertiary neonatal services remains significant, especially in regional areas where parents may need to relocate closer to a major centre late in pregnancy.

A related neonatal concern is respiratory distress in the early days of life, and clinicians working with high-risk infants frequently refer to current RSV prevention strategies when counselling families about what to expect after discharge.

Preterm birth and low birth weight

Even in singleton ART pregnancies, the risk of preterm birth and lower-than-expected birth weight remains modestly elevated. Meta-analyses that pool data from European, North American, and Australasian cohorts typically report a one-and-a-half to two-fold increase in the odds of delivery before 37 weeks, with the highest rates seen after ICSI and after conception using donor eggs. The reasons are multifactorial and include parental subfertility, hormonal influences on the early placenta, and a higher caesarean delivery rate.

For Australian families, this often translates into more antenatal visits, ultrasound monitoring of cervical length, and conversations about timing of delivery if complications emerge. Neonatal units in Queensland, Western Australia, and New South Wales have developed specific pathways for babies born after ART, recognising that early identification of feeding difficulties, temperature instability, and jaundice can shorten hospital stays.

Birth weight patterns are similarly influenced, with studies from the ANZARD database showing that ART singletons are on average 100 to 200 grams lighter than their naturally conceived peers. While most of these babies are well within the normal range, the slight shift matters at a population level because it nudges more infants across thresholds that trigger additional monitoring.

Placental issues and bleeding disorders

Placental abnormalities are a recurring theme in the ART literature. Studies have noted higher rates of placenta praevia, placental abruption, and abnormal cord insertion, particularly after IVF. These conditions function as obstetric emergencies in their own right and contribute to the higher caesarean delivery rate seen in ART pregnancies.

Equally important, though less frequently discussed outside specialist circles, are neonatal haematological complications. Thrombocytopenia, or a low platelet count in the newborn, can arise from a range of causes including maternal immune conditions, infections, and growth restriction. Babies conceived through ART who are also born preterm face an overlapping set of risks that obstetric and neonatal teams must evaluate together, and reviews of neonatal thrombocytopenia clinical approach provide useful guidance in these settings.

For clinicians in tertiary hospitals, early recognition of abnormal cord insertion on routine ultrasound helps guide decisions about timing of delivery and preparation of neonatal staff. When abruption occurs, rapid access to blood products and platelet transfusion capability become essential components of safe care.

Long-term health considerations

Concerns sometimes extend beyond the immediate perinatal period. Researchers have followed ART-conceived children into adolescence and adulthood to assess cardiometabolic, neurodevelopmental, and reproductive outcomes. Most reassuringly, large registry studies from Australia and Scandinavia have found no consistent increase in the risk of major congenital malformations once maternal factors are accounted for, though some specific anomalies such as certain cardiac and musculoskeletal conditions continue to show small elevations.

Blood pressure, insulin sensitivity, and vascular function have all been studied in ART cohorts, with subtle differences reported in some studies that may reflect epigenetic influences rather than the technology itself. Neurodevelopmental outcomes are broadly reassuring, although rates of cerebral palsy are higher in ART populations, largely because of the lingering effects of preterm birth and multiples.

These findings support a balanced view that recognises real but generally modest risks while affirming that the vast majority of children conceived through treatment grow up healthy. Parents who have access to ongoing paediatric follow-up, particularly through their local child and family health nurse or general practitioner, are well placed to catch any emerging issues early.

Comparing ART methods and their perinatal risk profiles

The comparison below summarises how the most common ART approaches stack up across four perinatal indicators that Australian families most often ask about. It draws on registry data from Australia and overseas to give a balanced overview, though individual experiences vary widely depending on parental health, embryo quality, and clinic protocols.

When reviewing these figures, it helps to remember that absolute differences are often small and that most ART babies are born healthy. Decisions about which technique to pursue are typically driven by clinical indications and patient preference rather than perinatal risk alone, and fertility specialists across the country can tailor approaches to each family's circumstances.

The most important message for Australian parents is that most ART pregnancies proceed without serious complications, and that the country's fertility and obstetric infrastructure is among the most developed in the world. Choosing a single embryo transfer, attending all scheduled antenatal appointments, and openly discussing concerns with midwives, obstetricians, and paediatricians all help ensure the safest possible outcome. If complications do arise, the pathways from clinic to hospital to neonatal unit are well established, particularly in major metropolitan centres where multidisciplinary teams collaborate daily.

Couples and individuals considering treatment, or already pregnant after ART, are encouraged to explore the published abstracts and educational resources from the FAOPS 2020 programme. The shared knowledge gathered from perinatal specialists across the Asia-Oceania region remains a valuable companion to local clinical care, helping families move forward with confidence and clarity.